That's what happened beginning in November of last year, anyway. The company announced solid testing results for VK2735. But ...

Immunotherapy shows promise in reducing recurrence rates for high-risk skin cancer, despite mixed results in recent clinical ...

Genentech, part of the Roche Group ( OTCQX:RHHBY) ( OTCQX:RHHBF) ( OTCPK:RHHVF ), announced that the U.S. FDA has rejected ...

A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...